researchers examined 1,714 samples over six months and found that just 39 per cent contained what they buyer thought they had been sold
.
.
.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.
.
.
.
submit a letter to the editor
.
.ai-based software may help predict risk of dementia
.
why novartis� landmark cancer drug approval is great news for bluebird
.
for the next several days, with relatives keeping a constant vigil, robert held the hand of his wife, who was hooked up to an iv and lethargic from pain medication.
.
meet other global citizens who care about the same issues you do. keep updated on what they're doing to change the world.